Halting of AstraZeneca jab as cases rise in Europe threatens vaccine programme
But the EMA remains convinced that the vaccine’s benefits ‘in preventing Covid-19, with its associated risk of hospitalisation and death, outweigh the risks of side effects’
Rome/Munich/Moscow — Europe’s slow vaccination push has sunk further into disarray after some of the biggest countries suspended AstraZeneca’s shot to explore its effects, compounding a crisis of confidence around a promising path out of the pandemic.
Germany, France and Italy decided on Monday in a co-ordinated step to suspend the use of the vaccine. Now the EU’s vaccine rollout hangs partly on the findings by the European Medicines Agency, which plans to decide on the next steps on Thursday. Concerns surrounding the shot are also likely to dominate a video conference by EU health ministers slated for later on Tuesday...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.